|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Multiple endocrine neoplasia [MEN] syndromes
ICD-10 (CM) Code and Descriptor
|
E31.21 |
Multiple endocrine neoplasia [MEN] type I
|
E3121 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.52%
|
23.57%
|
14.56%
|
7.84%
|
6.95%
|
4.45%
|
2.39%
|
2.11%
|
1.39%
|
0.56%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E31.21*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
221
|
223
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
205
|
205
|
|
80053
|
COMPREHEN METABOLIC PANEL |
156
|
156
|
|
83970
|
ASSAY OF PARATHORMONE |
117
|
125
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
104
|
104
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
102
|
116
|
|
84146
|
ASSAY OF PROLACTIN |
97
|
99
|
|
84443
|
ASSAY THYROID STIM HORMONE |
91
|
91
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
80
|
2,060
|
|
82941
|
ASSAY OF GASTRIN |
78
|
78
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
71
|
72
|
|
84439
|
ASSAY OF FREE THYROXINE |
70
|
70
|
|
82306
|
VITAMIN D 25 HYDROXY |
70
|
70
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
68
|
68
|
|
84305
|
ASSAY OF SOMATOMEDIN |
53
|
53
|
|
82533
|
TOTAL CORTISOL |
49
|
52
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
44
|
45
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
40
|
3,828
|
|
J1930
|
LANREOTIDE INJECTION |
39
|
4,680
|
|
84100
|
ASSAY OF PHOSPHORUS |
36
|
36
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E31.21 related to the following DRG Codes:
643-645
|
